An interventional study of Modified Specific carbohydrate diet for 3 months in Asthma in Children, sponsored by Tanta University. Not yet recruiting. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-07-14.
Sponsored by Tanta University · Not applicable, Interventional, and Treatment
The aim of this study will explore if the specific carbohydrate diet has an effect on asthma control in children and if it will affect the frequency, severity, and duration of asthma and thus provide it as a potential complementary treatment option for them.
This study will be carried out on 30 children with moderate persistent asthma presented to the outpatient clinic of the Pulmonology Unit, Pediatric Department, Tanta University Hospital.
All children at the start of the study will be subjected to full history taking including, full nutritional assessment, laboratory tests, Pulmonary function tests, and Anthropometric measurements
3,921 studies on the registry are indexed under Asthma; 507 are open to participants now.
This study's planned enrollment of 60 is below the median of 83 across 2,752 interventional studies indexed under Asthma.
Browse Asthma studies →Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.
Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Explore if the modified specific carbohydrate diet has an effect on asthma control in children and if it will affect the frequency, severity, and duration of asthma and thus provide it as a potential complementary treatment option for them.
Dietary Supplement: Modified Specific carbohydrate diet for 3 months
Assess control based on the usual asthma medications only
All children at the start of the study will be subjected to: 1. Full history taking including demographic and medical history 2. Full nutritional assessment including: Through clinical examination for any signs of vitamins and mineral deficiency, with full chest examination. 3. Laboratory tests: Complete blood picture with differential white blood cells, and Serum IgE level 4. At the beginning of the study and at the end 1. The patients will be assessed using the childhood-asthma control test (C-ACT) as a subjective method 2. Pulmonary function tests will be performed using spirometry (Spirostik, Geratherm) that includes Forced vital capacity (FVC), forced expiratory volume in the first second of FVC (FEV1), and FEV1/FVC. 3. Anthropometric measurements: Weight, Height, and Body mass index (BMI). All measures will be plotted on specific percentile curves for age and Z score
Childhood-asthma control test (C-ACT) as a subjective method
The C-ACT consists of a 7-item validated questionnaire, addresses the previous 4 weeks and is divided into two parts. One part is filled in by the child and consists of four questions on perception of asthma control, limitation of activities, coughing and awakenings at night. Each question has four response options. The second part is filled in by the parent or caregiver and consists of three questions (daytime complaints, daytime wheezing and awakenings at night) with six response options. The sum of all scores yields the C-ACT score, ranging from 0 (poorest asthma control) to 27 (optimal asthma control). A cut-off point ≤ 19indicates uncontrolled asthma
Time frame: Baseline (three months)
FEV1
Will be performed using spirometry (Spirostik, Geratherm) to measure forced expiratory volume at the end of the first second.
Time frame: three months
FVC
Will be performed using spirometry (Spirostik, Geratherm) to measure forced vital capacity.
Time frame: three months
FEV1/FVC ratio
Will be performed using spirometry (Spirostik, Geratherm) to measure the ratio of forced expiratory volume at the end of first second to the forced vital capacity.
Time frame: three months
No study locations are listed for this record.
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tanta University